INVESTIGATION ALERT: Khang & Khang LLP Announces An Ongoing Investigation of Claims against Zosano Pharma Corporation And Encourages Investors With Losses to Contact the Firm

IRVINE, CA / ACCESSWIRE / May 17, 2016 / Khang & Khang LLP announces that it is investigating claims of potential misrepresentations by Zosano Pharma Corporation (“Zosano” or the “Company”) (NASDAQ: ZSAN). The investigation focuses on whether the Company and its officers violated securities laws by issuing misleading information to investors.

If you purchased shares of Zosano during the Class Period, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.

There has been no class certification in this case. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

The investigation will focus on whether the Company’s filings with the SEC concerning its January 2015 Initial Public Offering were misleading. The Company offered more than 6,500,000 shares of its common stock at $11.00 per share in connection with its IPO.

If you wish to learn more about this lawsuit, or if you have any questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in some jurisdictions.

Contact:

KHANG & KHANG LLP
Joon M. Khang, Esq.
Telephone: 949-419-3834
Facsimile: 949-225-4474
joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 440110